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Abstract
Background: Direct synthesis of genes is rapidly becoming the most efficient way to make
functional genetic constructs and enables applications such as codon optimization, RNAi resistant
genes and protein engineering. Here we introduce a software tool that drastically facilitates the
design of synthetic genes.
Results: Gene Designer is a stand-alone software for fast and easy design of synthetic DNA
segments. Users can easily add, edit and combine genetic elements such as promoters, open
reading frames and tags through an intuitive drag-and-drop graphic interface and a hierarchical
DNA/Protein object map. Using advanced optimization algorithms, open reading frames within the
DNA construct can readily be codon optimized for protein expression in any host organism. Gene
Designer also includes features such as a real-time sliding calculator of oligonucleotide annealing
temperatures, sequencing primer generator, tools for avoidance or inclusion of restriction sites,
and options to maximize or minimize sequence identity to a reference.
Conclusion: Gene Designer is an expandable Synthetic Biology workbench suitable for molecular
biologists interested in the de novo creation of genetic constructs.
Background
DNA, like any other form of information, can be both
written and read. For DNA, reading is done by DNA
sequencing and writing by gene synthesis. Most of molec-
ular biology over the last decade has focused on reading
and analyzing naturally occurring DNA sequences as
revealed by massive worldwide sequencing efforts. In con-
trast, the emerging field of Synthetic Biology aims to write
new genetic information, thereby creating designed non-
natural genes, proteins, biological processes and organ-
isms[1]. Gene synthesis was conceived as a means of gene
acquisition in the 1970s and early 1980s[2,3], but was
soon overtaken by cloning from libraries and later by
PCR. More recently, protein and DNA sequences have
become easier to obtain electronically through databases
than physically from library clones. At the same time gene
synthesis technology has matured. Direct synthesis of
genes is rapidly becoming the most efficient way to make
functional genetic constructs and enables applications
such as codon optimization[4], making RNAi resistant
genes[5] and protein engineering[6].
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Synthetic Biology is the convergence of molecular biology
and engineering principles that is underpinned by increas-
ingly efficient technologies for creating full length genes,
operons and even genomes denovo [7-9]. Codon optimiza-
tion for heterologous protein expression has been shown
to often drastically increase protein expression levels[4].
Central to such efforts is the ability to design the genetic
constructs as easily as possible while considering multiple
design parameters in parallel. For example, considerations
such as codon bias use in the desired expression system,
avoidance of mRNA secondary structures, degree of
sequence identity to homologs and the presence or
absence of specific restriction sites or motifs must all be
considered simultaneously.
Current commercial sequence manipulation packages are
typically very feature rich with graphic user interfaces and
multiple integrated tools to allow for a seamless work-
flow. These commercial packages are primarily built to
read and analyze sequence information, giving very little
freedom to design and write new genetic information. On
the other hand there are a plethora of freely available soft-
ware that allow the user to simply codon optimize a
sequence. These free tools are usually poor on gene design
features, rely on a static web interface, are never updated,
and have very limited flexibility. A representative selection
of free codon optimization tools can be found in table 1
and also in reference[10]. These free codon optimization
tools rarely use probabilistic algorithms, do not support
features such as 'optimize close to' or 'far away from' a ref-
erence sequence, do not flag methylation sensitive restric-
tion enzymes or capture manual editing in real time etc.
These are all features that are incorporated in the codon
optimization module of Gene Designer. Equally impor-
tant, Gene Designer is built to integrate codon optimiza-
tion with all the tools necessary to design, write and edit
sequence information within one unifying user friendly
interface. The Gene Designer software enables the quick,
reliable and robust creation of new genetic information, a
process essential for Synthetic Biology.
Results
Input and manipulation of data
Gene Designer is easy and intuitive to learn. It has a graph-
ically rich molecular viewer for displaying and manipulat-
ing genetic constructs using simple drag-and-drop
manipulations, coupled with a hierarchical data structure
for storing, managing and accessing sequence objects.
Gene Designer is a stand-alone secure software that pro-
vides an efficient integrated solution for gene design
projects.
New sequence objects in Gene Designer can be entered as
AA (amino acid sequence), DNA (nucleotide sequence
object) or ORF (amino acid sequence linked to a nucle-
otide sequence). Each object can be imported directly in
FASTA format or manually imported by cut-and-paste
into a data entry window. Once loaded, each object can be
displayed in icon, sequence or notes (annotation) view.
A set of commonly used genetic objects are provided in a
tree structured Design Toolbox. The list includes prokary-
otic and eukaryotic transcriptional and translational regu-
latory elements, purification and solubility tags, protease
cleavage sites, secretion signals, restriction sites and
recombinase cloning elements. The toolbox is not a com-
plete and final list of genetic elements, but rather a con-
venient starting point for each user to assemble their own
custom set of genetic objects. The software is built to ena-
ble the user to add and edit new custom objects and make
notes associated with each object. These objects can be
saved in the toolbox and can be shared between users. For
Table 1: Public codon optimization softwares.




COD OP CUT, RE, DO Unix perl [52]
DNA Works CUT, RE, DO Web browser [53]
Codon Optimizer CUT, RE [54]
Prot2DNA CUT, RE, mSeq, Rep Precursor to Gene Designer [4]
Gene2Oligo DO Web browser [55]
UpGene CUT, DO [56]
GeMS CUT, RE, mSeq, DO Web browser [57]
JCat CUT, RE Web browser [58]
Synthetic Gene Designer CUT, RE, DO Web browser [59]
Software with features similar to the codon optimization module of Gene Designer. CUT indicates that one or more codon usage tables are 
referenced during reverse translation of the protein sequence. RE indicates that restriction endonuclease sites can be identified and silently 
removed and/or inserted. Rep indicates that repeats and/or inverted repeats can be silently removed. mSeq indicates that mRNA secondary 
structures can be silently removed. DO identifies software that includes a module for the design of oligonucleotides for gene synthesisBMC Bioinformatics 2006, 7:285 http://www.biomedcentral.com/1471-2105/7/285
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detailed and up to date information of each existing
building block, or to create new building blocks, we rec-
ommend the user searching NCBI databases and the
World Wide Web.
The Icon View provides an immediate overview of the
entire design project. Each genetic object is shown as a dif-
ferently colored arrow indicating the orientation of the
object. Objects can be moved in this view by drag-and-
drop. This is particularly convenient when moving affinity
tags from the N to the C-terminal of a protein, creating
chimeric proteins and editing restriction sites at ends of a
construct.
The Sequence View provides a detailed display of the
nucleotide and/or amino acid sequences of each object
below a single nucleic acid sequence corresponding to the
entire construct. For AA objects, each amino acid (single
letter code) is shown immediately above its correspond-
ing codons. Codons are shown in descending order of
their frequency in the corresponding codon usage table.
The Notes View provides a convenient way for the user to
annotate the sequence elements for future reference.
There is also a feature in the Notes View for reports on the
entire project.
Codon optimization
The genetic code uses 64 nucleotide triplets (codons) to
encode 20 amino acids and stop. Each amino acid is
encoded by on average 3 codons that are read during
translation by tRNAs charged with the cognate amino
acid. The degeneracy of the genetic code enables many
alternative nucleotide sequences to encode the same pro-
tein. The frequencies with which different codons are used
by different organisms and different types of genes vary
significantly[11] and are correlated to the concentration
of the corresponding tRNA population in the cell[12].
Rare codons are not only strongly associated with low lev-
els of protein expression due to ribosome stalling and
abortive translation[13], but also implicated in frameshift
and amino acid misincorporation[14,15]. Codon usage
has been identified as the single most important factor in
prokaryotic gene expression[16].
The simplest way to design a DNA sequence from an
amino acid sequence is to assign the most abundant
codon to all instances of that amino acid in the sequence.
Codon usage preference in a gene is often measured by
Codon Adaptation Index (CAI score). The CAI score for
such a construct is 1.0, i.e. in each case only the most
abundant codon is used. This 'one amino acid – one
codon' or 'CAI = 1.0' approach has several drawbacks.
First, a strongly transcribed mRNA from such a gene will
generate high codon concentrations for a subset of the
tRNA populations, resulting in imbalanced tRNA pool,
skewed codon usage pattern and increased translational
error[17]. Heterologously expressed proteins may be pro-
duced at levels as high as 60% of total cell mass, making
an imbalance tRNA pool a significant problem resulting
in reduced growth due to tRNA depletion[18] and
increased frameshift due to translational pausing at the
ribosomal A-site[19]. Second, with no flexibility in codon
selection, it is impossible to avoid repetitive elements and
mRNA secondary structures in the gene. Severe repetitive
elements can affect the genetic stability of a gene and may
lead to excision through recombination. Third, it is often
desirable to incorporate or exclude sequence elements
such as restriction sites from the sequence to facilitate sub-
sequent manipulations. These modifications are impossi-
ble to accommodate if the codon usage is rigidly fixed.
Fourth, in the literature there are many and sometimes
conflicting data suggesting sequence elements that
decrease protein expression levels. Such elements can not
be avoided if the codon usage is fixed. Gene Designer
users who wish to use the CAI = 1 optimization approach
can either increase the threshold for codons used or use a
modified codon usage table.
In contrast to the 'CAI = 1.0' method, Gene Designer opti-
mizes genes for expression by using a codon usage table in
which each codon is given a probability score based on
the frequency distribution of the codons in the genome
normalized for every amino acid. The codon usage tables
for 25 common protein expression hosts are included
with the download, and new codon usage tables can be
imported from the Codon Usage Database http://
www.kazusa.or.jp/codon[20] or manually edited as
required. The codon usage table created by one user is
automatically imported when another user shares the
project. For E. coli expression we recommend the user to
use the EColi_CII table that is derived from a collection of
highly expressed E. coli genes[21]. Candidate sequences
are generated in silico using a Monte Carlo algorithm by
selecting codons based on the probabilities obtained from
the codon usage table, with codons below the threshold
value (default is 10%) excluded from consideration. Each
designed sequence is then passed through subsequent
iterations to ensure a match with additional design criteria
such as filtering out mRNA secondary structures and DNA
repeats, eliminating or incorporating restriction sites and
avoiding methylation sites that overlap methylation sen-
sitive restriction sites[4]. A pseudo code for the algorithm
in Gene Designer can be found in appendix A.
Motifs such as internal Shine-Dalgarno sequences have
been shown to decrease gene expression[22]. Gene
Designer allows the user to filter out Shine-Dalgarno
sequences, splice donor and acceptor sequences as well as
any other sequence motif defined by the user. The user canBMC Bioinformatics 2006, 7:285 http://www.biomedcentral.com/1471-2105/7/285
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also maximize or minimize the similarity of the designed
sequence to a reference sequence, for example to make
RNAi-resistant genes[5] or to maximize the probability of
recombination between two variants. Since the algorithm
is a Monte Carlo based algorithm where each codon
choice is an independent probabilistic event, the software
can iterate the optimization each time finding a new and
equally good solution.
Gene Designer does not utilize advanced RNA folding cal-
culation software such as the popular mFold[23] as these
types of software are designed to calculate RNA secondary
structures for naked RNA. The translated mRNA within an
ORF is in fact densely covered by ribosomes. Chemical
footprinting of mRNA-ribosome complexes show that up
to 20 codons (60 bases) are covered by a single translating
ribosome[24], and the ribosomes are translating at ~18
codons (54 bp)/sec with one ribosome initiating transla-
tion every ~2 second[25] leaving only ~50 mRNA bases
available between translating ribosomes for folding an
mRNA secondary structure. During translation, a stem-
loop structure in the coding part of the mRNA does not
hinder the progress of the translational machinery, and
actively translating ribosomes can break up such struc-
tures, either by the energy driven translation process itself
or by the support of RNA helicases [26-28].
Gene Designer filters out (or flags, if it can not be avoided)
any mRNA structure with double-stranded RNA stem of
12 bp or more. This feature is included because it is very
often requested by users and also because it ensures that
oligonucleotides used in the gene synthesis process will
not predominantly self-anneal during gene assembly.
The codons immediately 3' of the initiation ATG codon
have a strong influence on gene expression[22,29-31].
Graphic user interface of Gene Designer Figure 1
Graphic user interface of Gene Designer. Section of the Gene Designer environment in Sequence view (top) with restric-
tion sites and object properties windows (bottom). Tm calculator and restriction-site denoted in Sequence view.BMC Bioinformatics 2006, 7:285 http://www.biomedcentral.com/1471-2105/7/285
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Accordingly, the codon optimization module in Gene
Designer gives the user the option to treat the 5' end of the
ORF separately. The default is conservatively set to include
the first 15 codons of the ORF as 5' end, but can be
changed as needed. Gene Designer will filter out NGG
codons in the 5' region[32] and predominantly use A/T in
the wobble position[33,34]. The 5' end is also set to filter
out repeats of 8 bases or more and filter out mRNA sec-
ondary structures of 8 bp or more.
The local context of a codon can influence the protein
expression levels. Back in the early 1980s it was shown
that the efficiency of the UAG stop codon in E. coli is typ-
ically decreased in the presence of a 3' adenine and
increased in the presence of a 3' cytidine[35,36]. Since
then, a multitude of experimentally validated codon con-
texts have been shown to affect ribosomal frameshift, mis-
sense and nonsense incorporations and translational
efficiency [37-40]. Gene Designer avoids known codon
context issues by omitting the use of rare codons and fil-
tering out runs of C's and G's. We also recommend the
addition of two stop codons at the end of an ORF to
ensure proper translational termination.
Aside from the experimentally validated cases of codon
context effect on protein expression levels, there are sev-
eral publications where in which codon context effects
have been proposed based on in silico analysis of genomes
[41-43]. The absence or low level of certain codon con-
texts in the analysis of entire genomes does not necessarily
reflect that the identified sequences affect protein expres-
sion of a recombinant gene when grown in rich media,
but more likely is a consequence of other evolutionary
pressures such as facilitating DNA replication, mutational
bias, expression during starvation, intrinsic metabolic reg-
ulation etc.. [44] In at least one case[45], the predicted
codon pair bias effect on protein expression could not be
experimentally validated[46]. The current version of Gene
Designer only includes pre-set sequence constraints that
have been experimentally validated. The individual user
may add to these any sequence elements they wish to
eliminate.
Other design features
Any object can be split into two or more daughters by
selecting a part of the sequence and using the Split func-
tion. Users can thus easily divide proteins into domains
for easy drag-and-drop construction of chimeras or gene
variants. Objects can also be linked within and between
projects; changes in linked objects then propagate
throughout all open projects. All changes, such as editing
an object's sequence, changing codon table or codon
threshold are incorporated into the final sequence in real
time.
The Gene Designer can also be used to design oligonucle-
otides. To assist with this, a real-time Tm calculator can be
positioned in the Sequence View and dragged until a pre-
ferred location, length and melting temperature is found.
The DNA melting temperature calculation is performed
using the nearest neighbor method[47,48]. The software
can also design sequencing primers for a specified region
or spanning the entire construct through an integrated
'Actions' module.
Once a sequence has been designed, sequences can be
saved with all the graphical elements and captured rela-
tionships as Gene Design files (.gd suffix), saved as a
graphic image (.jpeg) or as plain text (.txt). Reports can be
generated that contain the complete nucleotide sequence,
the nucleotide sequence of each object, notes, translation
map of each object, a restriction site summary, codon
usage frequencies and GC content. Finally, by clicking the
'Get quotation' or 'Order gene' icon, the designed syn-
thetic DNA fragment can be priced or placed in the gene
synthesis pipeline of DNA 2.0.
Conclusion
Gene Designer provides an easily accessible means of
designing synthetic genes, operons and other genetic con-
structs denovo. The user can combine and modify pre-
defined and custom genetic building blocks directly
through a user friendly drag-and-drop interface. All
manipulations needed for gene design are integrated and
immediately accessible under one interface.
The authors are using and have been using Gene Designer
daily over the last year. Several thousand genes have now
been designed using only this software. The savings in
time, increased convenience and reliability of Gene
Designer compared to other commercial and freeware
tools has dramatically improved our efficiency and ensure
a robust pipeline for sequence information handling. Fur-
thermore, applications such as creating RNAi resistant
genes[5] could only be enabled using the Gene Designer
software.
Please contact the authors to suggest features to include in
upcoming Gene Designer releases.
Availability and requirements
Gene Designer is freely available for download from the
'Tools' menu at http://www.DNA20.com. Both Mac and
PC versions are available. The software is provided "as is"
with no guarantee or warranty of any kind for non-com-
mercial use. Please see the download licensing agreement
for further licensing details and restrictions on commer-
cial use.BMC Bioinformatics 2006, 7:285 http://www.biomedcentral.com/1471-2105/7/285
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Appendix A. Pseudo-code for codon 
optimization in Gene Designer
FOR EACH A.A. sequence
FOR EACH codon in sequence
Select a codon randomly from the probability distri-
bution. †
FOR EACH A.A. sequence that needs homologue (aim-
ing/avoidance)
Prepare homologue alignment matrix.
Pre select codons that are (closest to/furthest from)
homologue sequence.
IF homologue dna contains unwanted restriction sites
or other unwanted sequences THEN
Ask/warn user and eliminate if necessary.
Create a Ukkonen Suffix Tree of the entire construct con-
catenated with its reverse compliment.
H = homologue score for all A.A. sequences that require it.
R = number of repeats over given threshold.
M = size of largest repeat.
WHILE R > 0 DO ‡
Change a codon in the largest repeat region based on the
probability distribution. †
Hnew = homologue score after change.
Rnew = number of repeats after change.
Mnew = size of largest repeat after change.





FOR EACH A.A. sequence that requires 5' translation opti-
mization
Create a Ukkonen Suffix Tree of the 5' end concatenated
with its reverse compliment.
Find hairpins in 5' end.
GCgoal = CG ratio wanted × 3 × number of codons being
considered in 5' end.
H = homologue score for the 5' end.
R = number of hairpins.
GC = total number of G's and C's in 5' end.
WHILE R > 0 OR GC > GCgoal DO ‡
Change a random codon in 5'end based on the prob-
ability distribution. †
Hnew = homologue score after change.
Rnew = number of hairpins after change.
GCnew = number of G's and C's after change.






FOR EACH restriction enzyme that needs to be checked
for methylation
Find methylated sites.
WHILE still methylated DO ‡BMC Bioinformatics 2006, 7:285 http://www.biomedcentral.com/1471-2105/7/285
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Change a codon in the site based on the probability
distribution. †
FOR EACH restriction enzyme that needs to be avoided.
Find restriction sites.
WHILE restriction site still exists DO ‡
Change a codon in the site based on the probability
distribution. †
† Based on a given precompiled codon bias table.
‡ This can go on forever, must be stopped artificially after
a given number of iterations
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